Product Name: Elagolix Sodium
Synonyms: N/A
CAS Number: 832720-36-2
Manufacturer: Pharmaceutical manufacturer name and address as provided on supplier documentation
Recommended Use: Pharmaceutical active ingredient
Contact Information: Emergency phone number, emergency response team, and technical information line from supplier documentation
Classification: Classified as hazardous based on criteria from regulation (such as OSHA Hazard Communication Standard or EU CLP)
GHS Label Elements: Hazard Pictogram(s), Signal Word, Hazard Statements (for example, Harmful if swallowed, Causes skin irritation, Risk of serious damage to eyes)
Precautionary Statements: Wash skin thoroughly after handling, avoid breathing dust or powder, wear protective gloves, eye protection
Physical Hazards: May form combustible dust concentrations in air
Health Hazards: May cause skin and eye irritation, respiratory tract irritation, may be harmful on ingestion
Chemical Name: Elagolix Sodium
Common Name: Elagolix Sodium
Concentration: >99% (active pharmaceutical ingredient)
CAS Number: 832720-36-2
Impurities or Stabilizers: Not expected to be present at concentrations relevant to hazard classification
Additives: None for pure API
Inhalation: Move individual to fresh air. Seek medical attention if symptoms develop or persist.
Skin Contact: Remove contaminated clothing. Wash affected area with ample water and soap. Obtain medical help if irritation continues.
Eye Contact: Rinse eyes cautiously with water for several minutes. Lift eyelids thoroughly. Seek medical advice if symptoms persist.
Ingestion: Rinse mouth thoroughly. Do not induce vomiting unless directed by medical personnel. Seek medical attention immediately.
Advice for Physicians: Symptomatic and supportive treatment should be provided.
Suitable Extinguishing Media: Water spray, dry chemical, carbon dioxide, foam
Unsuitable Extinguishing Media: Direct water jet may spread dust
Specific Hazards: Fine particles can present a combustible dust hazard. Fire or excessive heat can lead to irritating or toxic fumes and gases.
Special Protective Equipment for Firefighters: Wear self-contained breathing apparatus and standard protective gear. Remove all persons from vicinity if safe to do so. Prevent firefighting water runoff from entering drains or surface water.
Personal Precautions: Avoid inhaling dust or contact with skin or eyes. Use recommended personal protective equipment.
Environmental Precautions: Prevent product from entering drains, water courses or soil.
Methods for Cleanup: Wear appropriate respirator and gloves. Scoop up material without producing dust, place into secure containers for disposal. Clean the area thoroughly with appropriate detergent to avoid residue.
Emergency Procedures: Isolate area, restrict access, ventilate area.
Handling: Avoid contact with eyes, skin, and clothing. Do not breathe dust or powder. Use in a well-ventilated area or with adequate local exhaust. Handle in accordance with good industrial hygiene and safety practices.
Storage: Store tightly closed in a cool, dry, well-ventilated location, away from incompatible materials such as strong oxidizers. Protect from moisture and direct sunlight. Store separately from food and drink.
Exposure Limits: No specific occupational exposure limits established for Elagolix Sodium; use pharmaceutical dust exposure control limits as guidance.
Engineering Controls: Use local exhaust ventilation or other engineering controls to keep airborne levels below recommended exposure limits. Enclose processes and practice good containment methods.
Personal Protective Equipment:
Respiratory—Use NIOSH-approved respirator with particulate filter if dust exposure is possible.
Eyes—Wear safety glasses with side shields.
Skin—Wear suitable protective clothing and gloves made from materials that meet chemical resistance requirements. Remove contaminated clothing immediately.
Hygiene—Wash hands thoroughly after handling and before eating or drinking.
Appearance: White or off-white powder
Odor: Odorless or faint odor
Odor Threshold: Not established
pH: Not available
Melting Point: Information not established; typically in higher temperature range for pharmaceutical powders
Boiling Point: Not applicable (decomposes before boiling)
Flash Point: Not applicable for solid powder
Evaporation Rate: Not applicable
Flammability: May present combustible dust hazard
Vapor Pressure: Negligible for solid at room temperature
Relative Density: Not established
Solubility: Slightly soluble in water
Partition Coefficient (Log Kow): Data not available
Decomposition Temperature: Not established
Viscosity: Not applicable
Molecular Formula: C32H34F2N6Na2O5S2
Molecular Weight: Approximately 730.77 g/mol
Chemical Stability: Stable under recommended storage conditions
Conditions to Avoid: Excess heat, direct sunlight, formation of dust clouds
Incompatible Materials: Strong oxidizing agents
Hazardous Decomposition Products: Thermal decomposition can produce toxic fumes such as nitrogen oxides, sulfur oxides, carbon oxides, and fluorine-containing compounds.
Possibility of Hazardous Reactions: No dangerous reactions expected under normal use and storage
Routes of Exposure: Inhalation, skin and eye contact, ingestion
Acute Toxicity: Specific data unavailable; evaluate by analogy to related substances and published animal toxicity reports
Chronic Effects: Potential reproductive or developmental effects cited for related drug compounds; monitor for organ-specific effects with repeated exposure
Symptoms of Overexposure: Irritation to skin, eyes, mucous membranes; possible respiratory irritation; systemic toxicity at high doses
Carcinogenicity, Mutagenicity, Reproductive Toxicity: Results from long-term studies in animals and humans continue to be evaluated. No evidence for carcinogenicity or genotoxicity in recommended pharmaceutical uses.
Ecotoxicity: Limited data available; compounds in the same class can affect aquatic organisms at low concentrations
Persistence and Degradability: No specific data, but pharmaceutical substances tend to persist in the environment
Bioaccumulative Potential: Data insufficient; chemical structure suggests low tendency to bioaccumulate
Mobility in Soil: Not expected to exhibit high mobility; likely to adsorb to soils or sediments
Other Adverse Effects: Avoid direct release to the environment, water bodies, or sewage systems
Waste Disposal Methods: Incinerate or dispose of materials in accordance with national, regional, and local regulations. Do not discharge to drains or waters. Contaminated packaging should be evaluated as chemical waste.
Disposal of Product: Send to a licensed waste disposal contractor using appropriate containers. Do not reuse empty packaging.
Special Precautions: Avoid dust formation and exposure to personnel during disposal activities
UN Number: Not classified as hazardous for transport according to ADR/RID/IMDG/IATA
Transport Hazard Class: Not regulated
Packing Group: Not applicable
Environmental Hazards: Not regulated as a marine pollutant
Special Precautions for User: Avoid mechanical damage to packages during transit. Secure containers to prevent shifting and breakage.
TSCA Status: Not listed for non-commercial / research chemicals; always confirm with specific product documentation
REACH Registration: Substance may be subject to requirements under REACH if imported/manufactured in the EU; check details with the registration holder
SARA Title III: No components listed as reportable chemicals
California Proposition 65: Not listed as a carcinogen or reproductive toxin
Other Regulations: Handle as a regulated pharmaceutical substance in accordance with local legislation governing occupational safety, transportation, and disposal